Tesamorelin, is a growth-hormone-releasing hormone (GHRH) analogue used clinically for the treatment of HIV-associated lipodystrophy. (In lipodystrophy, fat accumulates excessively both in the abdomen and in other areas of the body.) It is also being researched for its ability to improve peripheral nerve health, slow the progression of mild cognitive impairment/dementia, and the reduction of fat mass.
Products are furnished for LABORATORY RESEARCH USE ONLY. This product should only be handled by qualified, and licensed professionals. The product may not be used as a drug, agricultural or pesticide product, food additive or household chemical – and may not be misbranded as such. All information on this website is available for educational purposes only. Bodily introduction of any kind into humans and/or animals is strictly forbidden by law